全文获取类型
| 收费全文 | 24701篇 |
| 免费 | 1168篇 |
| 国内免费 | 194篇 |
专业分类
| 耳鼻咽喉 | 331篇 |
| 儿科学 | 360篇 |
| 妇产科学 | 207篇 |
| 基础医学 | 2809篇 |
| 口腔科学 | 611篇 |
| 临床医学 | 1531篇 |
| 内科学 | 6435篇 |
| 皮肤病学 | 400篇 |
| 神经病学 | 2254篇 |
| 特种医学 | 955篇 |
| 外科学 | 4353篇 |
| 综合类 | 114篇 |
| 预防医学 | 869篇 |
| 眼科学 | 487篇 |
| 药学 | 1635篇 |
| 中国医学 | 47篇 |
| 肿瘤学 | 2665篇 |
出版年
| 2023年 | 130篇 |
| 2022年 | 93篇 |
| 2021年 | 503篇 |
| 2020年 | 269篇 |
| 2019年 | 327篇 |
| 2018年 | 434篇 |
| 2017年 | 332篇 |
| 2016年 | 433篇 |
| 2015年 | 442篇 |
| 2014年 | 634篇 |
| 2013年 | 805篇 |
| 2012年 | 1222篇 |
| 2011年 | 1353篇 |
| 2010年 | 731篇 |
| 2009年 | 673篇 |
| 2008年 | 1241篇 |
| 2007年 | 1296篇 |
| 2006年 | 1345篇 |
| 2005年 | 1441篇 |
| 2004年 | 1353篇 |
| 2003年 | 1284篇 |
| 2002年 | 1283篇 |
| 2001年 | 810篇 |
| 2000年 | 839篇 |
| 1999年 | 728篇 |
| 1998年 | 372篇 |
| 1997年 | 304篇 |
| 1996年 | 280篇 |
| 1995年 | 204篇 |
| 1994年 | 170篇 |
| 1993年 | 172篇 |
| 1992年 | 426篇 |
| 1991年 | 402篇 |
| 1990年 | 355篇 |
| 1989年 | 399篇 |
| 1988年 | 364篇 |
| 1987年 | 304篇 |
| 1986年 | 281篇 |
| 1985年 | 279篇 |
| 1984年 | 209篇 |
| 1983年 | 177篇 |
| 1982年 | 82篇 |
| 1979年 | 136篇 |
| 1978年 | 103篇 |
| 1977年 | 75篇 |
| 1974年 | 85篇 |
| 1973年 | 84篇 |
| 1972年 | 82篇 |
| 1971年 | 79篇 |
| 1969年 | 78篇 |
排序方式： 共有10000条查询结果，搜索用时 27 毫秒
1.
2.
3.
4.
5.
Kensuke Kudou Hiroshi Saeki Yuichiro Nakashima Shun Sasaki Tomoko Jogo Kosuke Hirose Qingjiang Hu Yasuo Tsuda Koichi Kimura Ryota Nakanishi Nobuhide Kubo Koji Ando Eiji Oki Tetsuo Ikeda Yoshihiko Maehara 《American journal of surgery》2019,217(4):757-763
Background
There were few studies assessed the postoperative sarcopenia in patients with cancers. The objective of present study was to assess whether postoperative development of sarcopenia could predict a poor prognosis in patients with adenocarcinoma of esophagogastric junction, (AEG) and upper gastric cancer (UGC).Methods
Patients with AEG and UGC who were judged as non-sarcopenic before surgery were reassessed the presence of postoperative development of sarcopenia 6 months after surgery. Patients were divided into the development group or non-development group, and clinicopathological factors and prognosis between these two groups were analyzed.Results
The 5-year overall survival rates were significantly poorer in the development group than non-development group (68.0% vs. 92.6%, P?=?0.0118). Multivariate analyses showed that postoperative development of sarcopenia was an independent prognostic factor for poor overall survival (P?=?0.0237).Conclusions
Postoperative development of sarcopenia was associated with a poor prognosis in patients with AEG and UGC. 相似文献6.
7.
Hiroto Kinoshita Hitomi Nishioka Aya Ikeda Kyoko Ikoma Yoichi Sameshima Hidehisa Ohi Mizuki Tatsuno Junka Kouyama Chiaki Kawamoto Tomohiro Mitsui Yuko Tamura Yu Hashimoto Masashi Nishio Tsuyoshi Ogashiwa Yusuke Saigusa Shin Maeda Hideaki Kimura Reiko Kunisaki Kazuhiko Koike 《Journal of gastroenterology and hepatology》2019,34(11):1929-1939
8.
9.
Comparative safety study on severe anemia by simeprevir versus telaprevir‐based triple therapy for chronic hepatitis C 
下载免费PDF全文
下载免费PDF全文 Eiichi Ogawa Norihiro Furusyo Eiji Kajiwara Hideyuki Nomura Akira Kawano Kazuhiro Takahashi Kazufumi Dohmen Takeaki Satoh Koichi Azuma Makoto Nakamuta Toshimasa Koyanagi Kazuhiro Kotoh Shinji Shimoda Jun Hayashi The Kyushu University Liver Disease Study Group 《Journal of gastroenterology and hepatology》2015,30(8):1309-1316
10.
Yoshinori Yanai Takeo Kosaka Kohei Nakamura Eriko Aimono Kazuhiro Matsumoto Shinya Morita Shuji Mikami Hiroshi Nishihara Mototsugu Oya 《Cancer science》2020,111(12):4652
Cyclin‐dependent kinase 12 (CDK12), one of the key factors associated with DNA damage response pathways, is located on chromosome 17 proximal to Erb‐B2 receptor tyrosine kinase 2 (ERBB2). In this report, CDK12 and ERBB2 coamplification was detected by targeted next‐generation sequencing in two urothelial carcinomas. The staining intensity of the CDK12 and human epidermal growth factor receptor‐2 proteins was associated with the prognosis of each urothelial carcinoma case. Our results suggest that CDK12 coamplification with ERBB2 might be associated with tumor aggressiveness and contribution to cancer pathogenesis. Therapies targeting CDK12 should be developed for these patients. 相似文献